J & J consumer products spinoff Kenvue goes public through $3.8B IPO
J&J spun off its consumer health division in order to "streamline" operations and focus on its pharmaceutical and medical device divisions.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: John George Source Type: news